


How to Address Opioid Abuse with Patients

FDA Action on Loperamide Misuse; Plus Phase 1 Trials for BAT2506 Biosimilar Begin

How to Improve Opioid Prescribing in an Outpatient Clinic

Measles Is Back. How Does This Affect Patients with Rheumatic Disease?

FDA Approves Risankizumab, Adds Stronger Warning to Sleep Medications

FDA Issues Boxed Warning for Febuxostat & Approves Colchicine for Gout Flare

Safety Risk with Higher Dose Tofacitnib

FDA Update: Priority Review for Non-Opioid Treatment & New Warning for Fluoroquinolones

The Perils of Pain Meds Revisited
- « Previous Page
- 1
- 2
- 3
- 4
- 5
- …
- 19
- Next Page »